Susan Miller, biochemist, Dow Chemical
Carl Mongiovi, vice president, Phamatech [Added: 2:45 pm, 3/15/10]
Deborah Mongiovi, associate director, clinical development, Halozyme Therapeutics [Added: 7 pm, 3/18/10]
Margaret Moore, principal investigator, Imdaptive
Kevin Nakamura, director of research, Astute Medical
Gina Nelson, pharmaceutical market research consultant [Added: 3:10 pm, 3/14/10]
Donna Nichols, investor relations professional
Randy Nielsen, manager of QC and stability, Catalent Pharma Solutions
Tina Nova, co-founder, president and CEO, Genoptix Medical
Susan Nowakowski, president and CEO, AMN Healthcare Services
Janice Ohta, board member, Caltech Associates
Karl Olsen, chief financial officer and head of operations, GNF
Paul O’Shaughnessy, senior marketing manager, off-portal content, AT&T Mobility
Cole Owen, president, Owen & Associates [Added: 1:15 pm 3/12/10]
Bob Parson, vice president of global clinical and regulatory affairs, Inverness Medical Innovations
Jim Patterson, Owner/Partner, System1Search [Added: 8:05 pm, 3/14/10]
Philip Paul, Chairman, Paul Capital Partners [Added: 8:30 pm, 3/14/10]
Melinda (Hackett) Paulis, marketing consultant [Added: 7 pm, 3/18/10]
Greg Payne, director, BD
Liz Perkins, associate director of marketing communications, Prometheus Laboratories
Caryn Peterson, partner, DSC Associates
Leigh Pierce, president and CSO, PacificGMP
Ken Poggenburg, independent pharmaceuticals professional
Norbert Purro, director of pharmaceutical sciences, Pharmacyclics [Added: 3:40 pm, 7/7/10]
Noorul Rahman, consultant at TRL Enterprises
Pamela Resch, director, regulatory affairs, Vical [Added: 9:25 am, 3/15/10]
Lyle Rice, vice president of development, LEAP Biosciences [Added: 10 am, 3/23/10]
Don Rindell, executive director, Amylin Pharmaceuticals
Mark Robertson, owner, Mark Robertson Puppets
Steve Roman, senior scientist, Life Technologies
